Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,424 public trials 2,855 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents

NCT05334823

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • Beijing Children's Hospital.Capital Medical University Beijing, Beijing Municipality, China
  • Beijing GoBroad Boren Hospital Beijing, Beijing Municipality, China
  • Pediatric Hematology department of Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China
  • Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China
View Trial Details
Recruiting

Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)

NCT05546580

Conditions
Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Hematologic Diseases, +6 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • The University of Arizona Cancer Center - North Campus Tucson, Arizona, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Miami Cancer Institute Miami, Florida, United States
View all 13 locations
View Trial Details
Recruiting

Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients

NCT06520176

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Dongyang People's Hospital Dongyang, Zhejiang, China
  • The First Affiliated Hospital, College of Medicine, Zhejiang University Hangzhou, Zhejiang, China
  • Tongde Hospital of Zhejiang Province Hangzhou, Zhejiang, China
  • Huzhou central hospital Huzhou, Zhejiang, China
View all 16 locations
View Trial Details
Recruiting

Results From a French Temporary Utilization Authorization of First-line Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Chemotherapy (IC), Treated With Venetoclax Azacitidine

NCT06263387

Conditions
AML, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Amiens CHU Amiens, France
  • Angers CHU Angers, France
  • Avignon CH Avignon, France
  • Bayonne CH Bayonne, France
View all 42 locations
View Trial Details

Related conditions